Search

Your search keyword '"cost-effectiveness analysis"' showing total 22,973 results

Search Constraints

Start Over You searched for: Descriptor "cost-effectiveness analysis" Remove constraint Descriptor: "cost-effectiveness analysis"
22,973 results on '"cost-effectiveness analysis"'

Search Results

101. Reducing overdose deaths among persons with opioid use disorder in connecticut

102. Fetoscopic laser versus amnioreduction, septostomy, and expected management for the treatment of twin-twin transfusion syndrome (TTTS): an economic evaluation analysis in Iran

103. Cost-effectiveness and cost–benefit analyses of fluoride varnish for caries prevention in Guangxi, China

104. Cost‑effectiveness analysis of tislelizumab plus chemotherapy in Chinese patients with advanced or metastatic oesophageal squamous cell carcinoma.

105. Cost-effectiveness of train-the-trainer versus expert consultation training models for implementing interpersonal psychotherapy in college mental health settings: evidence from a national cluster randomized trial.

106. The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study.

107. The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China.

108. Economic analysis of digital motor rehabilitation technologies: a systematic review.

109. COST EFFECTIVENESS ANALYSIS KOMBINASI AMLODIPIN-KANDESARTAN DIBANDINGKAN AMLODIPIN-IRBESARTAN PADA HIPERTENSI KOMORBID DIABETES MELLITUS TIPE 2 DI RSUD GOETENG TAROENADIBRATA.

110. ОЦЕНКА НА РЕНТАБИЛНОСТТА НА СКРИНИНГОВИ ПРОГРАМИ ЗА ДИАБЕТНА РЕТИНОПАТИЯ - СИСТЕМАТИЧЕН ПРЕГЛЕД

111. The economic evaluation of an Internet-based parental wellbeing intervention.

112. Cost-effectiveness analysis of metformin versus insulin in the treatment of gestational diabetes mellitus.

113. Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions.

114. Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled Trial.

115. Cost‐effectiveness analysis of single colonoscopy versus single fecal test for colorectal cancer diagnosis and treatment.

116. Landscape and challenges in economic evaluations of artificial intelligence in healthcare: a systematic review of methodology.

117. Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Standard of Care in Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain.

118. 10 years of decision‐making for biodiversity conservation actions: A systematic literature review.

119. Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan.

120. Bone Marrow Biopsies: Is CT, Fluoroscopy, or no Imaging Guidance the Most Cost-Effective Strategy?

121. The survival and cost-effectiveness analysis of adjunctive Chinese medicine therapy for patients with non-small cell lung cancer: a nationwide cohort study in Taiwan.

122. A comparative study of population management approaches in infectious disease control, population management of fisheries and wildlife, and integrated pest management in agriculture.

123. Cost-effectiveness Analysis of Colorectal Cancer Screening Strategies Using Active Learning and Monte Carlo Simulation.

124. Health utility values of breast cancer treatments and the impact of varying quality of life assumptions on cost‐effectiveness.

125. Cost-effectiveness analysis of different anesthesia strategies for transperineal MRI/US fusion prostate biopsy.

126. Cost-effectiveness analysis of Anaprazole versus Ilaprazole for the treatment of duodenal ulcers in China.

127. Cost-Effectiveness of Community-Based Active Case Finding Strategy for Tuberculosis: Evidence From Shenzhen, China.

128. A retrospective cohort study of intra-corporeal versus extra-corporeal anastomosis for right hemicolectomy with cost-effectiveness analysis.

129. Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States.

130. Cost-effectiveness of brentuximab vedotin compared with conventional chemotherapy for relapsed or refractory classic Hodgkin lymphoma in China.

131. Can Robotic Arm‐assisted Total Knee Arthroplasty Remain Cost‐effective in Volume‐based Procurement System in China? A Markov Model‐based Study.

132. Economic evaluations of treatment of depressive disorders in adolescents: Protocol for a scoping review.

133. Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses.

134. Establishing an EU‐wide front‐of‐pack nutrition label: Review of options and model‐based evaluation.

135. A Comparison of Healthcare Funding Systems between Low-/Medium-Income and High-Income Countries: Equity, Equality, and Fairness in the Rationing of Healthcare Resources.

136. Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of 4 Candida auris Screening Methods.

137. Effect of Educational Intervention on Reducing Mobile Phone Addiction: Application of Transtheoretical Model.

138. Cytoreductive surgery plus hyperthermic intraoperative peritoneal chemotherapy for people with peritoneal metastases from colorectal, ovarian or gastric origin: A systematic review of randomized controlled trials.

139. Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective.

140. Cost-effectiveness of restorative treatments for permanent molars with severe molar incisor hypomineralization: perspectives for the Brazilian public health system.

141. A Review of the Cost-Effectiveness Evidence for FDA-Approved Cell and Gene Therapies.

142. Impact of infectious density-induced additional screening and treatment saturation on COVID-19: Modeling and cost-effective optimal control.

143. Cost-Effectiveness Analysis of Fluocinolone Acetonide Intravitreal (FAI) Implant for Chronic Noninfectious Uveitis Affecting the Posterior Segment of the Eye (NIU-PS) in China.

144. Cost-effectiveness analysis of endovascular versus open repair in patients with abdominal aortic aneurysm in Iran: a cross-sectional study.

145. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.

146. Economic value of toripalimab plus axitinib as first-line treatment for advanced renal cell carcinoma in China: a model-based cost-effectiveness analysis.

147. Optimizing Non-Point Source Pollution Management: Evaluating Cost-Effective Strategies in a Small Watershed within the Three Gorges Reservoir Area, China.

148. Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China.

149. Cost‐effectiveness analysis of abrocitinib compared with standard of care in adult moderate‐to‐severe atopic dermatitis in Japan.

150. Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective.

Catalog

Books, media, physical & digital resources